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Introduction {#sec1}
============

Embryonic stem cells (ESCs) are the pluripotent counterparts of the preimplantation epiblast and are an invaluable model for understanding the first steps of mammalian development. These cells show rapid self-renewal and retain the potential to contribute to all derivatives of the three germ layers: endoderm, mesoderm, and ectoderm. Over the past few years, much has been learned about the mechanisms controlling ESC pluripotency ([@bib22]), but little is known regarding the mechanisms that control cell survival at the pluripotent stage and during the first stages of embryonic differentiation. It has been particularly hard to uncover whether there is any surveillance mechanism that detects cells that carry mutations that, although they would not adversely affect viability, would compromise their ability to contribute to further development. In the mouse embryo, apoptosis peaks just prior to the onset of gastrulation ([@bib6; @bib16; @bib29]). In addition to this, coincident with the start of embryonic differentiation, the embryo becomes hypersensitive to DNA damage induced by low-dose irradiation ([@bib13]). This suggests that, during these stages, cellular fitness and viability are likely to be tightly monitored.

Cell competition is a type of cell-cell interaction first studied in *Drosophila*, where the coexistence of two cell populations with different metabolic properties or growth rates results in the growth of the stronger population at the expense of the weaker one. This process of recognition and elimination of vulnerable, mispatterned, or abnormal cells during tissue growth has been proposed to play important roles in tissue homeostasis, organ size control, stem cell maintenance, and the expansion of precancerous cell fields ([@bib9; @bib14; @bib33]). Here, we find that ESCs that display defective bone morphogenetic protein (BMP) signaling or defective autophagy or are tetraploid are eliminated at the onset of differentiation in an apoptosis-dependent manner, only in the presence of wild-type cells. Furthermore, we show that c-Myc is a key mediator in this process. We argue that these observations are remarkably reminiscent of what has been described as cell competition in other systems. Our data therefore demonstrate an involvement of cell competition in regulating cellular fitness during the first steps of embryonic differentiation in mammals.

Results {#sec2}
=======

Cells with Defective BMP Signaling Are Eliminated in the Presence of Wild-Type Cells {#sec2.1}
------------------------------------------------------------------------------------

BMP signaling is required for maintaining self-renewal and pluripotency of ESCs ([@bib34]) and of the mouse postimplantation epiblast ([@bib11]). In embryos carrying a null mutation for *Bmpr1a*, the main type I BMP receptor during early postimplantation development, the entire epiblast undergoes neural differentiation ([@bib11]). However, in mosaic *Bmpr1a*^−*/*−^ embryos, mutant cells are capable of contributing to all germ layers, suggesting that they have no autonomous defect during the first steps of germ layer differentiation ([@bib8; @bib11]). Careful inspection of *Bmpr1a*^−*/*−^ mosaics generated with the *Mox2-Cre* deletor line revealed that a proportion of mutant cells were being eliminated by apoptosis at the epiblast stage of postimplantation development ([Figure 1](#fig1){ref-type="fig"}A). In the *Drosophila* wing, cells that carry a mutation in the *Bmpr1a* homolog *Thick veins* (*Tkv*) have a competitive disadvantage over wild-type cells and are eliminated by apoptosis ([@bib2]). Given that ESCs have proven to be a remarkable model for the first steps of differentiation, we turned to this system to test if the elimination of *Bmpr1a* null cells was due to the presence of wild-type cells.

*Bmpr1a*^−*/*−^ ESCs can still transduce BMP signaling, but the level of activation of this pathway is reduced compared to that of control cells ([Figure 1](#fig1){ref-type="fig"}B). In spite of this, as we have previously reported ([@bib11]), *Bmpr1a*^−*/*−^ ESCs have a similar pluripotent status to that of wild-type cells ([Figure S1](#app3){ref-type="sec"} available online). To analyze the behavior of *Bmpr1a*^−*/*−^ ESCs in the presence of wild-type cells, we labeled the mutant cells with green fluorescent protein (GFP), and the two cell types were cocultured. N2B27 media was used for these experiments, as this allows ESCs cells to progress into a state that transcriptionally resembles the postimplantation epiblast ([Figure S2](#app3){ref-type="sec"}A) ([@bib1; @bib32]). Time-lapse analysis revealed that, over a 4-day period, the proportion of *Bmpr1a*^−*/*−^*-GFP* cells was dramatically reduced in these cultures ([Figure 1](#fig1){ref-type="fig"}C). To establish if this was due to the presence of wild-type cells, we cultured *Bmpr1a*^−*/*−^*-GFP* ESCs and control ESCs separately or together. Analysis of their growth curves and of the ratio of control ESCs to *Bmpr1a*^−*/*−^ ESCs (obtained by flow cytometry) in each of these conditions revealed that, from day 3 in N2B27, the total number of *Bmpr1a*^*−/−*^*-GFP* ESCs decreased specifically in coculture ([Figure 1](#fig1){ref-type="fig"}D). This led to a significant increase in the proportion of control cells at days 3 and 4 of coculture, compared to separate populations ([Figure 1](#fig1){ref-type="fig"}D; [Table S1](#app3){ref-type="sec"}). Calculation of the growth rate for each cell type in separate and coculture conditions indicated that accompanying the decrease in numbers of *Bmpr1a*^−*/*−^*-GFP* ESCs was a significant increase in the growth rate of control cells ([Figure 2](#fig2){ref-type="fig"}A; [Table S1](#app3){ref-type="sec"}), suggesting that they undergo compensatory proliferation. When unlabeled *Bmpr1a*^−*/*−^ ESCs were cultured with E14 (control) GFP-labeled cells to exclude a possible deleterious effect of GFP, we observed a similar phenomenon ([Figures S2](#app3){ref-type="sec"}B and S2C; [Table S1](#app3){ref-type="sec"}).

To address whether the decrease in the numbers of *Bmpr1a*^−*/*−^ ESCs was due to apoptosis, we analyzed whether the addition of the pancaspase inhibitor ZVAD-FMK could prevent the elimination of *Bmpr1a*^−*/*−^ ESCs in coculture. We observed that, at day 3, mixed colonies exhibited large amounts of cellular debris of *Bmpr1a*^−*/*−^*-GFP* ESCs that could be visualized as punctuate dots of GFP by confocal microscopy ([Figures 2](#fig2){ref-type="fig"}B and [S2](#app3){ref-type="sec"}D). However, addition of ZVAD-FMK from the second day of culture abolished the elimination of *Bmpr1a*^−*/*−^*-GFP* cells and led to the disappearance of GFP-positive cellular debris in coculture ([Figure 2](#fig2){ref-type="fig"}B; [Table S1](#app3){ref-type="sec"}).

To investigate the possibility that the elimination of *Bmpr1a*^−*/*−^ ESCs was due to selection against a specific lineage, we analyzed the expression of lineage-specific markers in *Bmpr1a*^−*/*−^*-GFP* and control ESCs. We observed that *Bmpr1a*^−*/*−^*-GFP* ESCs in coculture showed an expression profile of mesoderm, endoderm, neural, and epidermal marker gene expression that was very similar to when they were cultured as a homogeneous population ([Figure S2](#app3){ref-type="sec"}E). Together, these results indicate that *Bmpr1a*^−*/*−^ ESCs are eliminated by apoptosis when in the presence of wild-type cells and that this elimination is not specific to any particular lineage.

Elimination of *Bmpr1a*^−*/*−^ Cells Is Dependent on the Onset of Differentiation {#sec2.2}
---------------------------------------------------------------------------------

*Bmpr1a*^−*/*−^ embryos only display defects at postimplantation stages ([@bib11]), and in mosaics, a proportion of *Bmpr1a*^−*/*−^ cells are eliminated by apoptosis at 6.5 days postcoitum (dpc) ([Figure 1](#fig1){ref-type="fig"}A). We therefore asked if the elimination of *Bmpr1a*^−*/*−^ cells was dependent on exit of the ground state of pluripotency, which is thought to exist in preimplantation embryos and ESCs ([@bib22]). We first analyzed whether the elimination of *Bmpr1a*^−*/*−^ cells occurred when these cells were differentiated to epiblast stem cells (EpiSCs). When this was done, we observed that the total numbers of *Bmpr1a*^−*/*−^ ESCs decreased from the third day of coculture with control cells in EpiSC media (N2B27 containing Activin and fibroblast growth factor \[FGF\]) ([@bib1; @bib32]) but not when they were cultured alone in these conditions ([Figure 2](#fig2){ref-type="fig"}C). We then analyzed what occurred when exit of pluripotency was suppressed by culturing the cells in serum plus Lif, BMP4 plus Lif, or in 2i (a MEK inhibitor and a GSK3β inhibitor). Interestingly, when we analyzed the ratios of control ESCs to *Bmpr1a*^−*/*−^ ESCs in all of these conditions, we observed that they were similar for cells grown separately or in coculture ([Figure 2](#fig2){ref-type="fig"}D; [Table S1](#app3){ref-type="sec"}). This indicates that, under conditions that maintain pluripotency, the elimination of *Bmpr1a*^−*/*−^ ESCs is abolished and, therefore, that the outcompetition of these cells only occurs when differentiation has been initiated.

Secreted Factors Regulate the Elimination of *Bmpr1a*^−*/*−^ Cells {#sec2.3}
------------------------------------------------------------------

Given that initiation of differentiation is dependent on a wide array of growth factors, we first tested whether the elimination of *Bmpr1a*^−*/*−^ cells requires cell contact. To test this, we cultured *Bmpr1a*^−*/*−^ and control ESCs on Corning Transwell polycarbonate membrane cell culture inserts. In this system, cells of one genotype are cultured on the base of the well, and those of another genotype are cultured on a filter in an insert that lies 1.2 mm over the base of the well. We found that there was no significant difference in the numbers of control or *Bmpr1a*^−*/*−^ ESCs when these were grown for 4 days with cells of the same genotype overlaying them or in the numbers of control cells when they were grown with overlaying *Bmpr1a*^−*/*−^ ESCs ([Figure 3](#fig3){ref-type="fig"}A). In contrast, when *Bmpr1a*^−*/*−^ ESCs were grown with overlaying control cells, their numbers were significantly lower than those of the other combinations tested ([Figure 3](#fig3){ref-type="fig"}A), indicating that secreted factors in the shared media must mediate their elimination. Interestingly, a similar finding has been made for cell competition in *Drosophila* ([@bib26]).

We next asked if the elimination of *Bmpr1a*^−*/*−^ ESCs was due to defective BMP signaling. For this, we transfected *Bmpr1a*^−*/*−^ ESCs with a CAG-*Bmpr1a* expression cassette (*Bmpr1a*^GOF^) and analyzed their behavior in coculture assays. We found that restoring BMP signaling in *Bmpr1a*^−*/*−^ ESCs rescued their elimination in mixed cultures but also led them to induce elimination of nontransfected *Bmpr1a*^−*/*−^ ESCs ([Figures S3](#app3){ref-type="sec"}A--S3C; [Table S1](#app3){ref-type="sec"}). These results indicate that the outcompetition of *Bmpr1a*^−*/*−^ ESCs in coculture is due to the deficiency in transducing BMP signaling.

An attractive model to explain the elimination of *Bmpr1a*^−*/*−^ ESCs is that defective BMP signaling made *Bmpr1a*^−*/*−^ ESCs less capable of competing for limiting amounts of BMPs that act as a survival factor ([@bib19; @bib20]). To analyze whether limiting BMP availability would enhance the elimination of *Bmpr1a*^−*/*−^ ESCs, we performed cocultures of *Bmpr1a*^−*/*−^ and control ESCs in the presence of the BMP antagonist Noggin and of the fusion protein BMPR1A-FC, a soluble dominant-negative form of BMPR1A. To test whether providing an excess of BMPs would rescue the disadvantage of *Bmpr1a*^−*/*−^ ESCs, we used either BMP4 or BMP7. We observed that, after 3 days of coculture in N2B27, Noggin decreased Smad1/5/8 phosphorylation in control and *Bmpr1a*^−*/*−^ ESCs. In contrast to this, BMP4 increased Smad1/5/8 activation in control, but not *Bmpr1a*^−*/*−^, ESCs. This led to an overall increase in the difference of BMP signaling between control and *Bmpr1a*^−*/*−^ ESCs ([Figures S4](#app3){ref-type="sec"}A and S4B). In spite of this, BMP4, BMP7, Noggin, and BMPR1A-FC did not significantly alter the ratio of *Bmpr1a*^−*/*−^ to control ESCs either separately or as cocultures ([Figure 3](#fig3){ref-type="fig"}B). These data suggest that, although defective BMP signaling leads to the elimination of mutant ESCs, cells are not competing for limiting amounts of BMPs, and the relative level of BMP signaling is not triggering their elimination.

Given these observations, we asked if other signaling pathways could be mediating the cell nonautonomous elimination of *Bmpr1a*^−*/*−^ ESCs. Given that inhibition of FGF signaling and BMP plus Lif are two conditions that block the elimination of *Bmpr1a*^−*/*−^ ESCs ([Figure 2](#fig2){ref-type="fig"}D), we asked whether excess FGF4, FGF5, or Lif affected this process. Interestingly, we observed that while FGF4 and FGF5 had little effect on the elimination of *Bmpr1a*^−*/*−^ ESCs, Lif completely abolished their competitive disadvantage in coculture ([Figure 3](#fig3){ref-type="fig"}B; [Table S1](#app3){ref-type="sec"}). This suggests that the signaling events downstream of Lif are a key element to the mechanism by which cells sense the defective status of *Bmpr1a*^−*/*−^ ESCs. To address if the activity of Lif was specific to the ground state of pluripotency, we tested the effect of Lif when added from day 2 of coculture in N2B27. We observed that once differentiation had been initiated, Lif only partially rescued the elimination of *Bmpr1a*^−*/*−^ ESCs ([Figure 3](#fig3){ref-type="fig"}B). Interestingly, analysis of the expression of components of the Lif pathway in ESCs after a 3 day culture in N2B27 indicated that the levels of *gp130* and *Stat3* were reduced ([Figure S4](#app3){ref-type="sec"}C). Furthermore, we observed that Lif was also less efficient at triggering Stat3 phosphorylation when *Bmpr1a*^−*/*−^ ESCs were cultured in N2B27 ([Figure 3](#fig3){ref-type="fig"}C). This indicates that, once ESCs have exited the ground state of pluripotency, Lif is less efficient at signaling and suggests that, although events downstream of Lif may be mediating the elimination of *Bmpr1a*^−*/*−^ ESCs, Lif itself is not directly involved in cell competition.

Autophagy-Deficient and Tetraploid ESCs Are Also Eliminated by Wild-Type Cells {#sec2.4}
------------------------------------------------------------------------------

Our finding that cells with defective BMP signaling are eliminated by wild-type cells prompted us to ask if this also occurred with cells carrying other defects. Autophagy is an intracellular degradation pathway that plays a pleiotropic role in the protection and maintenance of cellular life as well as in the response to starvation. Atg5 is a critical component of the autophagy pathway. *Atg5*-deficient ESCs are defective in ATP metabolism and, although they display apparently normal growth, upon differentiation are unable to engulf apoptotic cells ([@bib24]). When control and *Atg5*^−*/*−^ ESCs were cultured for 4 days in N2B27, we observed that, from the third day of culture, the numbers of *Atg5*^−*/*−^ ESCs decreased specifically when cocultured with control cells ([Figure 4](#fig4){ref-type="fig"}A; [Table S1](#app3){ref-type="sec"}). Interestingly, this competitive elimination was not observed when *Atg5*^−*/*−^ ESCs were cocultured with *Bmpr1a*^−*/*−^ ESCs ([Figure S4](#app3){ref-type="sec"}D; [Table S1](#app3){ref-type="sec"}), suggesting that ESCs must be capable of measuring their relative cellular fitness.

Elimination of polyploid cells from a normal genetic environment has been shown to occur in vivo ([@bib12]). In tetraploid (or 4n) chimeras, 4n cells can be found in the epiblast at 6.5 dpc but are lost from this tissue thereafter. For this reason, we asked if tetraploid ESCs could also be subject to competition when cultured with diploid (or 2n) cells. Analysis of the growth rate of 4n ESCs indicated that they proliferated at a constant rate, but this proliferation was significantly lower than control cells ([Figure 4](#fig4){ref-type="fig"}B). In contrast to this, when 4n ESCs were cocultured with diploid ESCs, their numbers decreased from the second day of coculture ([Figures 4](#fig4){ref-type="fig"}B and 4C; [Table S1](#app3){ref-type="sec"}). This decrease was found to be due to apoptosis, as tetraploid cells showed higher levels of annexin V staining than control cells and these levels were significantly higher in the cocultured condition compared to when these cells were cultured separately ([Figure 4](#fig4){ref-type="fig"}C). To test whether a similar phenomenon occurred in vivo, we generated chimeras using GFP-labeled tetraploid ESCs. We found that, at 6.5 dpc, the vast majority of tetraploid cells also showed cleaved-caspase 3 staining, indicating that, in the embryo, these cells were also eliminated by apoptosis ([Figure 4](#fig4){ref-type="fig"}D).

A possible explanation for the elimination of tetraploid or *Atg5*^−*/*−^ ESCs is that they have defective BMP signaling. To address whether this could be the case, we analyzed the ability of both these lines to respond to BMP4 after a 3 day culture in N2B27, when the elimination of defective cells occurs. We observed that, after stimulation with BMP4, both tetraploid and *Atg5*^−*/*−^ ESCs induced robust Smad1/5/8 phosphorylation, indicating that BMP signaling was normal in these cells ([Figure S5](#app3){ref-type="sec"}A). We next analyzed if defective autophagy could be the cause for the elimination of *Bmpr1a*^−*/*−^ or tetraploid cells. For this, we analyzed expression of LC3, a protein that switches from its LC3-I to its LC3-II isoform upon the induction of autophagy, and p62, a protein that is degraded during autophagy. We observed that, after a 3 day culture in N2B27, *Bmpr1a*^−*/*−^ and tetraploid ESCs displayed a similar ratio of LC3-I to LC3-II expression and levels of p62 expression similar to that of control ESCs, indicating that they were not defective in autophagy ([Figure S5](#app3){ref-type="sec"}B).

A third possibility is that defective ploidy could be a defect common to the eliminated cells. This possibility can be discarded, as *Bmpr1a*^−*/*−^ ESCs have a normal karyotype (data not shown) and the elimination of these cells can be rescued by reintroducing into them the *Bmpr1a* gene ([Figures S3](#app3){ref-type="sec"}A--S3C). Together, these data point to a general mechanism that is monitoring ESC fitness upon the onset of differentiation in a non-cell-autonomous fashion rather than to a defect that is common among *Bmpr1a*^−*/*−^, *Atg5*^−*/*−^, and tetraploid ESC lines.

c-Myc Is a Key Mediator of the Elimination of Defective ESCs {#sec2.5}
------------------------------------------------------------

The MYC family of transcription factors has been implicated in a variety of biological processes, including apoptosis and cell cycle regulation ([@bib7]). Furthermore, in *Drosophila*, d-Myc has been shown to be a key regulator of cell competition in the wing epithelium and in the developing ovary ([@bib10; @bib19; @bib25]). In ESCs, c-Myc acts downstream of Lif in the control of self-renewal ([@bib4; @bib27]), and for these reasons, we addressed the possible involvement of c-Myc in the elimination of *Bmpr1a*^−*/*−^ ESCs. Cells of different genotypes were sorted by fluorescence-activated cell sorting (FACS) on the basis of their GFP expression, and either messenger RNA (mRNA) or protein were isolated. Analysis of *c-Myc* mRNA levels revealed that these were similar in N2B27 for both *Bmpr1a*^−*/*−^*-GFP* and control ESCs, regardless of being in coculture or not ([Figure S6](#app3){ref-type="sec"}A). In contrast to this, c-Myc protein levels were significantly increased specifically in wild-type ESCs only when cocultured with *Bmpr1a*^−*/*−^*-GFP* cells ([Figure 5](#fig5){ref-type="fig"}A). This suggests that differential c-Myc protein levels may be a key event in the elimination of *Bmpr1a*^−/−^ ESCs. To test this, we first analyzed what occurred when these assays were performed in the presence of Lif or of MEK inhibition, two conditions that prevent the elimination of *Bmpr1a*^−*/*−^ ESCs ([Figure 2](#fig2){ref-type="fig"}). We observed that both these treatments abolished the differential c-Myc protein levels found between control and *Bmpr1a*^−*/*−^*-GFP* ESCs ([Figure 5](#fig5){ref-type="fig"}B). Next, we analyzed what occurred in the cocultures of *Atg5*^−*/*−^ or tetraploid-GFP ESCs with control cells and found that, when either of these cell types was cocultured with control cells, they downregulated c-Myc expression ([Figures 5](#fig5){ref-type="fig"}C and 5D).

These observations prompted us to address if there was any correlation between c-Myc levels and cell death in vivo. Analysis of *c-Myc* mRNA and protein expression showed that it was heterogenous in embryos 6.5 dpc but was absent from the epiblast 7.5 dpc ([Figures 6](#fig6){ref-type="fig"}A and 6B). Interestingly, a similar pattern was observed for cell death, as high levels were observed at 6.5 dpc and dramatically reduced by 7.5 dpc ([Figure 6](#fig6){ref-type="fig"}C). Furthermore, costaining for cell death (using TUNEL) and c-Myc revealed that, in the epiblast 6.5 dpc, those cells that were dying preferentially showed low levels of c-Myc expression ([Figure 6](#fig6){ref-type="fig"}D). These results suggest that the establishment of differential levels of c-Myc is a common mechanism regulating the elimination of aberrant ESCs.

To test this hypothesis further, we analyzed if c-Myc overexpression is sufficient to induce the elimination of wild-type cells. For this, we generated a tamoxifen-inducible c-Myc overexpression line and analyzed its behavior when cocultured with E14-GFP ESCs. Overexpression of c-Myc had been reported to maintain cells in the pluripotent state ([@bib4]), and given that we have shown that cell competition only occurred once ESCs had initiated differentiation ([Figure 2](#fig2){ref-type="fig"}), we first allowed cells to differentiate and then stimulated c-Myc activation. Control cells carrying a tamoxifen-inducible *c-Myc* construct (E14-cMycER) and E14-GFP cells were cocultured or grown separately for 3 days without tamoxifen, and then tamoxifen was added for a further 3 days ([Figure S6](#app3){ref-type="sec"}B). Analysis of the growth curves of E14-cMycER and E14-GFP cells in each condition indicated that, in the presence of tamoxifen, E14-cMycER cells grew at a similar rate in both the separate and coculture conditions ([Figure 6](#fig6){ref-type="fig"}E). In contrast to this, E14-GFP cells changed their behavior from an exponential growth rate under separate conditions to growth arrest when cocultured with c-Myc-overexpressing cells ([Figure 6](#fig6){ref-type="fig"}E; [Table S1](#app3){ref-type="sec"}), indicating that they were being eliminated by E14-cMycER cells.

In separate cultures in the presence of tamoxifen, the growth of E14-cMycER cells was slower than that of E14-GFP ESCs. Given that we observed that the expression of c-MycER was heterogeneous in these cultures (data not shown), it is possible that, in E14-cMycER separate cultures, high-expressing c-Myc cells are eliminating low-expressing cells. Alternatively, it is possible that the overexpression of c-Myc is having toxic effects on these cells. We also observed that, when E14-cMycER cells were grown without tamoxifen, they were enriched in coculture compared to when grown separately ([Figure S6](#app3){ref-type="sec"}C; [Table S1](#app3){ref-type="sec"}), suggesting that the system may be leaky to some degree. Overall, our data suggest that the establishment of differential levels of c-Myc is a key event in the elimination of "unfit" embryonic stem cells.

Discussion {#sec3}
==========

ESCs possess the unique ability to contribute to all the derivatives of the three germ layers as well as to self-renew in an indefinite fashion. In the embryo, their pluripotent counterparts will give rise to all the different tissues and cell types that compose the fetus. For this reason, the recognition and elimination of vulnerable, mispatterned, or abnormal cells is critical not only for the proper maintenance of the pluripotent stem cell pool but also for the correct development of the different organs of the newborn. In the mammalian embryo, the initiation of gastrulation marks the onset of embryonic differentiation and is associated with the start of rapid proliferation cycles ([@bib15; @bib28; @bib30]). A potential cost of this very rapid proliferation rate is the likelihood of a high production of damaged cells. It is thus expected that, at this stage, mechanisms are set in place to monitor epiblast fitness.

Apoptosis in the early mouse embryo peaks just prior to the onset of gastrulation and has been associated to the process of cavitation ([@bib6; @bib16; @bib29]). Furthermore, coincident with the start of gastrulation, the embryo also becomes hypersensitive to DNA damage induced by low-dose irradiation and undergoes apoptosis ([@bib13]). Tetraploid cells are eliminated from the epiblast in 4n:2n chimeras at 6.5 dpc, when gastrulation is being initiated ([@bib12]), and here we show that this occurs by apoptosis. Similarly, we find that cells with defective BMP signaling or defective autophagy are also eliminated at the epiblast stage of embryonic development. This suggests the existence of a general mechanism monitoring stem cell fitness upon the onset of differentiation in a non-cell-autonomous fashion. Our studies indicate that the establishment of differential levels of c-Myc is crucial to the elimination of defective cells, leading to the death of those cells with lower c-Myc levels. This is a feature that occurs both during ESC differentiation and in the epiblast of the 6.5 dpc embryo. Interestingly, c-Myc expression is reduced when the ground state of pluripotency is captured using GSK3β and MEK inhibition ([@bib35]). Given that blocking GSK3β activity increases c-Myc stability in ESCs ([@bib4]), this suggests that the MEK inhibitor must decrease c-Myc levels in 2i. We find that MEK inhibition blocks the elimination of *Bmpr1a*^−*/*−^ ESCs; therefore, one possible reason for why these cells are not eliminated in the ground state of pluripotency may be this effect of MEK inhibition on c-Myc levels. Alternatively, the mechanisms that govern cell death between the naive and primed states of pluripotency may differ.

Our findings are also of relevance to the tetraploid complementation experiments, where, to test the developmental potential of ESCs, they are injected into tetraploid embryos. In these chimeras, 4n cells can be found in the epiblast at 6.5 dpc ([@bib12]) but very rarely contribute to the embryonic tissue after 9.5 dpc. Our data indicate that this is because they are eliminated due to their competitive disadvantage. This observation, however, means that the conclusions from this type of complementation experiments should be treated with caution. If those ESCs that are used also have defects that affect their fitness, then it is possible that the tetraploid cells will persist for longer and, therefore, this will affect the interpretation of the experiment.

The mode of elimination of defective cells that we observe here shares several common features with what has been described as cell competition in *Drosophila* and other organisms ([@bib9; @bib14; @bib33]); for this reason, we argue that cell competition may be monitoring cellular fitness in the early mammalian embryo. Together, our data suggest that the elimination of defective stem cells in the postimplantation epiblast follows sequential steps ([Figure 7](#fig7){ref-type="fig"}). First, a mutual sensing step between cells is likely to occur, allowing identification of those that present a lower "fitness" level. Our experiments indicate that this lower level of cellular "fitness" is a relative rather than an absolute measure, as defective cells are viable when cultured as a homogeneous population. Furthermore, our experiments show that this first step is likely to be mediated, at least in part, by secreted factors, but we cannot rule out the contribution of cell-cell contact in further downstream events. Our finding that mammalian cells are capable of measuring their relative signaling abilities, growth rates, or metabolic rates is of great importance for our understanding of how cells behave in a heterogeneous population, not just how they act as individual entities.

The second step in the process is that, in response to the mutual sensing between normal and defective ESCs, differential levels of c-Myc are established between "fit" and "unfit" cells. We propose that, once differential levels of c-Myc are established, a second "mutual sensing" event occurs, acting as a second checkpoint to establish the final outcome of the competition. Our data indicate that this second sensing event is also cell nonautonomous, as control cells are eliminated when cocultured with c-Myc-overexpressing cells. It is after this step that activation of the apoptotic pathway and elimination of the "weaker" cells occurs. We believe that this process of recognition and elimination of vulnerable, mispatterned, or abnormal cells during tissue growth is of broad interest, as it will be fascinating to unravel if it also plays an important role in tissue homeostasis, organ size control, and stem cell maintenance at later stages of development or in the adult.

Experimental Procedures {#sec4}
=======================

ESC Culture and Manipulation {#sec4.1}
----------------------------

E14 ESCs were a gift from Prof. A. Smith (Cambridge University). *Bmpr1a*^−*/*−^ ESCs were described elsewhere ([@bib11]). *Atg5*^−*/*−^ ESCs were a gift from Noboru Mizushima ([@bib18]). Three tetraploid ESC lines were used, and these were derived during an electroporation experiment and determined to have 80 chromosomes by karyotyping. Cells were maintained following standard conditions and as described elsewhere ([@bib3]).

### Cell Competition Assays {#sec4.1.1}

After dissociation with Trypsin-EDTA, cells were counted and 4.2 × 10^4^ cells/cm^2^ plated into 0.1% gelatin-coated six-well plates. Cells were plated as each genotype separately or as a mixture of control and mutant ESCs at either a 50:50 or 40:60 ratio depending on the cell type. After plating, ESCs were incubated for 4 to 5 hr in ESC media without LIF and then washed and kept in N2B27 ESGRO Basal media (Milipore) for the specified times. Media were changed daily thereafter. We observed that competition also occurred when plating in Dulbecco's modified Eagle's medium plus serum; therefore, where indicated, this condition was also used. c-Myc induction was carried out with 4-hydroxytamoxifen (Sigma) at 10 nM. For analysis of the growth curves, 4.2 × 10^4^ cells/cm^2^ were plated for separate cultures and cocultures, and then cells were counted daily. The cell count graphs represent the total cell number of each genotype counted. For cells in coculture, the total number of cells in the mix was counted, and the relative proportion of cells of each genotype was determined by flow cytometry. It is worth noting that, as control and mutant cells represent only a proportion of the total cell number in the cocultures, this number is lower than the totals for each genotype when grown separately.

The graph columns represent the ratio of control to mutant ESCs. For maximum accuracy, the precise proportion of cells of each genotype present in coculture was obtained by FACS analysis. For the separate cultures, cells were trypsinized, mixed in equal volumes, and analyzed by flow cytometry.

### Growth Rate Calculations {#sec4.1.2}

The growth rate was calculated for each cell type in each condition for the different time points analyzed using the following equation: growth rate (in cell doublings per day) equals natural logarithm (final cell number/initial cell number) divided by the natural logarithm of two. A minimum of three independent experiments were performed, and the average ± SEM was plotted.

### Caspase Inhibition {#sec4.1.3}

We plated 4.0 × 10^5^ cells in a six-well plate and then cultured them from day 2 for 48 hr in the presence of the pan-caspase inhibitor Z-VAD-FMK (R&D Systems) at a final concentration of 100 nM. A minimum of three independent experiments were performed, and the average ± SEM is plotted.

### Growth Factor/Inhibitor Treatments {#sec4.1.4}

Cells were cultured in the presence of 1,500 U/ml LIF (Chemicon), 10 ng/ml BMP4, 25 ng/ml BMP7, 50 ng/ml Noggin, 250 ng/ml BMPR1A-FC, 5 ng/ml FGF4, 10 ng/ml FGF5 (all from R&D Systems), 1 μM PD0325901 (Sigma), or 3 μM CHIR99021 (Millipore) in serum-free N2B27.

Mice and Embryos {#sec4.2}
----------------

*Bmpr1a*^−*/fx*^-; *Mox2Cre*^+/−^ mice were generated as described elsewhere ([@bib17]). Mice on a mixed CD1 and 129/Sv background were used for the cell death and expression analysis. All mice were maintained on a 10 hr-14 hr light-dark cycle. Noon of the day of finding a vaginal plug was designated 0.5 dpc. Embryo dissection and chimera generation were carried out as described elsewhere ([@bib21]). All mice were maintained and treated in accordance with the Home Office's Animals (Scientific Procedures) Act 1986.

Immunostaining and Whole-Mount In Situ Hybridization {#sec4.3}
----------------------------------------------------

Immunostaining was carried out as described elsewhere ([@bib23]), with minor modifications. Briefly, embryos were fixed in 4% paraformaldehyde (PFA) + 0.1% Tween + 0.01% Triton for 20--30 min at room temperature (RT) and then washed three times in PBS + 0.1% Triton (PBT) for 5 min. Embryos were permeabilized with 0.4% Triton in PBS for 20 min and then washed three times for 10 min in PBT. Embryos were then blocked in 2% horse serum in PBT for 45 min at RT and then incubated with the antibody overnight at 4°C in (1:2) blocking solution in PBS. Antibodies used were 488-conjugated rabbit anti-GFP (1:300; Invitrogen), rabbit anti-cleaved caspase 3 (1:400; Cell Signaling), and rabbit anti-c-Myc (1:250; Abcam Y69 clone). Phalloidin-TRITC (Sigma) was used at 1:100. Whole-mount in situ hybridization (WISH) was carried out as described elsewhere ([@bib31]).

TUNEL and c-MYC Staining on Embryos {#sec4.4}
-----------------------------------

TUNEL cell death staining was carried out according to manufacturer's conditions (Promega DeadEnd Fluorometric TUNEL System), with the following modifications. Once dissected, embryos were fixed in 4% PFA + 0.1% Tween + 0.01% Triton for 20--30 min at RT, washed three times in PBT for 5 min, and permeabilized with 0.4% Triton in PBS for 20 min. Then, TUNEL staining was performed as indicated in the kit; once completed, embryos were stained for c-MYC using a tyramide signal amplification system (PerkinElmer TSA Cyanine Plus 3 Evaluation Kit) as described elsewhere ([@bib5]).

Western Blot Analysis {#sec4.5}
---------------------

For the analysis of cells in cocultures, the different genotypes were separated by FACS based on GFP expression. Cells were lysed in radio immunoprecipitation assay buffer containing Complete Mini Protease Inhibitors (Roche) and Phosphatase Inhibitors Set II (Calbiochem). Protein extracts (5--40 μg) were resolved by a 10% SDS-PAGE gel and subjected to western blot analysis. Primary antibodies used were rabbit anti-c-MYC (N-262 clone, 1:200), rabbit anti-phospho-Smad1/5/8 (1:1,000; Cell Signaling), rabbit anti-LC3 (1:300; Abgent), mouse anti-p62 (1:1,500; BD Bioscience), (rabbit anti-PCNA (1:5,000; Santa Cruz), and rabbit anti-tubulin (1:5,000; Cell Signaling).

For clonal assays, flow cytometry, annexin V staining, electroporation, RNA isolation, quantitative real-time PCR, and microarray analysis, see [Supplemental Experimental Procedures](#app3){ref-type="sec"}.

Accession Numbers {#app1}
=================

The GEO accession number for our microarray data is [GSE48092](ncbi-geo:GSE48092){#intref0010}.

Supplemental Information {#app3}
========================

Document S1. Supplemental Experimental Procedures, Figures S1--S6, and Table S1
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![Cells with Defective BMP Signaling Are Eliminated in the Presence of Wild-Type Cells\
(A) High levels of apoptosis in *Bmpr1a*^−*/*−^ cells in *Bmpr1a*^−*/fx*^;*Mox2Cre*^+/−^ embryos (n = 5/7). act-Casp3, cleaved (activated) Caspase3.\
(B) Phosphorylation of Smad1/5/8 in the described media (left) and Id gene activation in BMP4 + Lif (right) are decreased in *Bmpr1a*^−*/*−^ ESCs. PCNA, proliferating cell nuclear antigen.\
(C) Time-lapse imaging of cocultured control and *Bmpr1a*^−*/*−^*-GFP* ESCs.\
(D) Growth curves (left) and ratio (right) of control to *Bmpr1a*^−*/*−^ ESCs show that *Bmpr1a*^−*/*−^*-GFP* ESCs are outcompeted when cultured with control cells in N2B27. A minimum of three independent experiments were performed, and the average ± SEM was plotted. t, time. ^∗∗^p \< 0.005, Student's paired t test.\
See also [Figure S1](#app3){ref-type="sec"} and [Table S1](#app3){ref-type="sec"}.](gr1){#fig1}

![ESCs with Defective BMP Signaling Are Eliminated by Apoptosis upon Exit of the Ground State of Pluripotency\
(A) Growth rates (in cell doublings per day) of control and *Bmpr1a*^−*/*−^ ESCs between days 3 and 4 of culture indicate that, while *Bmpr1a*^−*/*−^ ESCs are eliminated, control cells undergo compensatory proliferation. Sep., separate culture; Co-Cul., coculture.\
(B) Ratio obtained by flow cytometry and confocal images of *Bmpr1a*^−*/*−^ and control cells indicates that addition between days 2 and 4 of coculture of the pancaspase inhibitor ZVAD-FMK blocks the elimination of *Bmpr1a*^−*/*−^ ESCs. DMSO, dimethyl sulfoxide.\
(C) Growth curves (left) and ratios (right) of control and *Bmpr1a*^−*/*−^ ESCs showing that the elimination of mutant cells occurs under EpiSC culture conditions.\
(D) Ratio of control to *Bmpr1a*^−*/*−^ ESCs showing that the outcompetition of *Bmpr1a*^−*/*−^*-GFP* ESCs is prevented by FCS + Lif, BMP4 + Lif, 2i, CHIR99021, or PD0325901. A minimum of three independent experiments were performed, and the average ± SEM was plotted. ^∗^p \< 0.05, and ^∗∗^p \< 0.01; a one-way analysis of variance (ANOVA) followed by Tukey's test.\
See also [Figures S2](#app3){ref-type="sec"} and [S3](#app3){ref-type="sec"} and [Table S1](#app3){ref-type="sec"}.](gr2){#fig2}

![Elimination of *Bmpr1a*^−*/*−^ ESCs Depends on Secreted Factors\
(A) Assays using Corning Transwell inserts indicate that the growth of *Bmpr1a*^−*/*−^ ESCs is inhibited when these cells are grown with overlaying control cells in N2B27. Cell numbers refer to the cells growing underneath the insert; the genotype of the cells growing on the insert is indicated in brackets.\
(B) Plot of the ratio of control to *Bmpr1a*^−*/*−^ ESCs cultured as separate populations or cocultured in the presence of Noggin (p = 0.15), Bmpr1a-Fc (p = 0.48), BMP4 (p = 0.97), BMP7 (p = 0.51), FGF4 (p = 0.33), FGF5 (p = 0.93), and Lif from day 0 (p = 0.0001) or from day 2 (p = 0.06). The plot shows that only when Lif is added from day 0 of coculture is the outcompetition of *Bmpr1a*^−*/*−^ ESCs significantly blocked.\
(C) Western blot showing that Lif is less efficient in triggering Stat3 phosphorylation once differentiation is initiated. A minimum of three independent experiments were performed, and the average ± SEM was plotted. pStat3, phosphorylated Stat3. ^∗∗^p \< 0.005, Student's paired t test.\
See also [Figure S4](#app3){ref-type="sec"} and [Table S1](#app3){ref-type="sec"}.](gr3){#fig3}

![Autophagy-Deficient and Tetraploid ESCs Are Eliminated by Cell Competition\
(A) Growth curves and plots of the ratio of control to *Atg5*^−*/*−^ ESCs in separate culture or coculture.\
(B) Growth curves and plots of the ratio of control to tetraploid ESCs in separate culture or coculture.\
Both (A) and (B) indicate that both autophagy deficiency and tetraploidy induce cell competition.\
(C) Histograms for Annexin V levels in control and tetraploid ESCs in separate culture or coculture in EpiSC media.\
(D) Immunostaining for cleaved-caspase 3 in chimeras generated with tetraploid-GFP ESCs (n = 10).\
Both (C) and (D) indicate that the tetraploid ESCs are eliminated by apoptosis both in vitro and in vivo. A minimum of three independent experiments were performed, and the average ± SEM was plotted. ^∗∗^p \< 0.005, Student's paired t test.\
See also [Figure S5](#app3){ref-type="sec"} and [Table S1](#app3){ref-type="sec"}.](gr4){#fig4}

![Establishment of Differential c-Myc Levels Is Critical for the Elimination of Defective ESCs\
(A and B) In (A), western blot analysis and quantification of relative c-Myc/PCNA intensity indicate that c-Myc protein expression is significantly downregulated in *Bmpr1a*^−*/*−^ ESCs at day 3 of coculture with control cells, but (B) shows that this difference is abolished by Lif and MEK inhibition using PD0325901.\
(C and D) c-Myc levels are also lower in (C) *Atg5*^−*/*−^ ESCs and in (D) tetraploid ESCs when cocultured with control ESCs. Cells in coculture were sorted by FACS based on GFP expression prior to analysis. A minimum of three independent experiments were performed, and the average ± SEM was plotted. ^∗^p \< 0.05, and ^∗∗^p \< 0.01; a one-way ANOVA was followed by Tukey's test.\
See also [Figure S5](#app3){ref-type="sec"}.](gr5){#fig5}

![c-Myc Is a Key Mediator of the Elimination of Defective ESCs\
(A and B) WISH in (A) and immunostaining in (B) show that *c-Myc* is heterogeneously expressed in embryos at 6.5 dpc but that this expression is downregulated from the embryonic region by 7.5 dpc. The lower image is a magnification of the region highlighted by the square.\
(C) TUNEL staining indicates that cell death peaks at 6.5 dpc in the embryo.\
(D) Double staining for TUNEL and c-Myc shows that those cells that are dying (white arrows) show low levels of c-Myc expression.\
(E) Growth curves and plot of the ratio of c-MycER and control ESCs when grown for 3 days in N2B27 and then treated with tamoxifen for 3 days in separate and coculture conditions, showing how c-Myc overexpression induces the elimination of control cells. A minimum of three independent experiments were performed, and the average ± SEM was plotted. ^∗∗^p \< 0.005, Student's paired t test.\
See also [Figure S6](#app3){ref-type="sec"} and [Table S1](#app3){ref-type="sec"}.](gr6){#fig6}

![Model for How Cell Competition Eliminates Defective Stem Cells during Early Mammalian Development\
A first step during cell competition is the mutual sensing that allows identification of those stem cells that present a lower "fitness" level. In response to the mutual sensing, differential levels of c-Myc are established between "fit" and "unfit" cells. Next, a second "mutual sensing" event occurs that monitors c-Myc levels, leading to activation of the apoptotic pathway and elimination of the "weaker," low c-Myc-expressing stem cells.](gr7){#fig7}
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